Assessment of the Safety, Efficacy, and Benefit of Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Heart Failure With Reduced Ejection Fraction (HFrEF) at High Risk for Cardiovascular Events

Background Since the increasing prevalence of type 2 diabetes mellitus (T2DM), heart failure coexisting with it has had a significant impact on clinical management and prognosis. Patients with T2DM and heart failure with reduced ejection fraction (HFrEF) have increased mortality and morbidity. Empag...

Descripción completa

Detalles Bibliográficos
Autores principales: Towiargi, Ruba, Fetyani, Lama, Aljahdali, Naila, Alnofeie, Adnan, Alnoamy, Yahya, Ghandorah, Reham, Abduljawad, Abrar, Alharbi, Njood, Alghanmi, Alanoud, AlButi, Hala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883530/
https://www.ncbi.nlm.nih.gov/pubmed/36721538
http://dx.doi.org/10.7759/cureus.33070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883530/
https://www.ncbi.nlm.nih.gov/pubmed/36721538
http://dx.doi.org/10.7759/cureus.33070

Ejemplares similares